Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKOLDERS' EQUITY

v3.20.2
CONSOLIDATED STATEMENTS OF STOCKOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Treasury Stock, at Cost [Member]
Total
Balance at Sep. 30, 2018 $ 574,687 $ 95,496,506 $ (581,519) $ (58,201,651) $ (7,806,605) $ 29,481,418
Balance (in Shares) at Sep. 30, 2018 57,468,660          
Share-based compensation   1,906,098       1,906,098
Shares issued in connection with public offering and common stock purchase agreement, net of fees and costs $ 71,429 9,060,538       9,131,967
Shares issued in connection with public offering and common stock purchase agreement, net of fees and costs (in Shares) 7,142,857          
Sale of shares under common stock purchase agreement $ 20,000 3,580,000       3,600,000
Sale of shares under common stock purchase agreement (in Shares) 2,000,000          
Amortization of deferred costs   (101,981)       (101,981)
Issuance of shares pursuant to share-based awards $ 6,104 326,896       333,000
Issuance of shares pursuant to share-based awards (in Shares) 610,434          
Net loss       (12,017,366)   (12,017,366)
Balance at Sep. 30, 2019 $ 672,220 110,268,057 (581,519) (70,219,017) (7,806,605) 32,333,136
Balance (in Shares) at Sep. 30, 2019 67,221,951          
Share-based compensation   2,646,246       2,646,246
Shares issued in connection with public offering and common stock purchase agreement, net of fees and costs $ 2,121 678,816       680,937
Shares issued in connection with public offering and common stock purchase agreement, net of fees and costs (in Shares) 212,130          
Sale of shares under common stock purchase agreement $ 41,421 13,358,578       13,399,999
Sale of shares under common stock purchase agreement (in Shares) 4,142,070          
Amortization of deferred costs   (390,931)       (390,931)
Issuance of shares pursuant to share-based awards $ 3,621 411,843       415,464
Issuance of shares pursuant to share-based awards (in Shares) 362,091          
Issuance of shares pursuant to common stock purchase warrants $ 1,091 (1,091)        
Issuance of shares pursuant to common stock purchase warrants (in Shares) 109,143          
Net loss       (18,973,535)   (18,973,535)
Balance at Sep. 30, 2020 $ 720,474 $ 126,971,518 $ (581,519) $ (89,192,552) $ (7,806,605) $ 30,111,316
Balance (in Shares) at Sep. 30, 2020 72,047,385